Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
FINEORG
Mr. Tushar Ramesh Shah · Mumbai, India
₹4,794.00
▲+0.07%FINEORG.NS is trading at a relatively high valuation multiple on its slow-growing specialty chemicals business, which is also burdened with rising debt.
Exchange
NSI
Currency
INR
Day range
₹4,783.00 – ₹4,864.50
52-week range
₹3,856.00 – ₹5,407.00
Sector
Basic Materials
Industry
Specialty Chemicals
AI investment rating
AI analysis60% confidence
FINEORG.NS appears to be trading near the upper end of its 1-year range, suggesting that its current valuation multiple may be slightly stretched considering its modest revenue growth
11.3% below the 1-year high · trend down
Hedge-fund memo
Today
The stock's 0.07% gain is a relatively muted response to the overall market's minor uptrend, with volume levels indicating a moderate level of interest.
This week
The stock's week-over-week performance is lackluster, trading largely flat in a sideways market.
This month
FINEORG.NS has underperformed its peers in the sector, down 6.5% over the last month as the industry struggles to adapt to macro-economic headwinds.
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Bullish
2 headlines · 2 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 2 of 4 recent quarters (EPS actual vs. consensus).
38.32 vs 27.8
37.84% surprise
24.11 vs 30.5
-20.95% surprise
35.4 vs 35.7
-0.84% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FINEORG | 146.98B | 35.26 | 16.82% | 18.07% | 2.40% |
| GALAXYSURF | 69.51B | 26.00 | 10.47% | 6.72% | 14.80% |
| ALKYLAMINE | 92.95B | 51.72 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Debt levels and profitability are under pressure from intense competition and declining product demand
Mitigation: —
Rising global and domestic economic uncertainty may lead to a sustained demand shock, impacting revenue growth and profitability
Mitigation: —
FINEORG.NS may struggle to maintain its market share and pricing power due to the aggressive entry of international companies into the domestic market
Mitigation: —
Business intelligence
Competitive moat
FINEORG.NS's manufacturing footprint and low-cost production structure provide a durable competitive advantage in the domestic specialty chemicals market.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
No notable recent activity flagged.
Catalyst calendar
Improvement in revenue growth, margins, and profit outlook
Thesis builder
Bull case
FINEORG.NS is poised for a moderate recovery in revenue growth, driven by improved product mix and stable domestic demand, with a potential upside of 15-20% over the next 12-18 months.
Base case
A sustained period of slow revenue growth and modest profit margins may lead to a steady-state price range around 4500 INR, with a potential upside of 0-5% over the next 3-6 months.
Bear case
The shares may be vulnerable to a sharp decline if rising debt levels, intensified competition, and worsening profit margins lead to a 10-20% decline in valuation.
Time horizon
—
Est. CAGR
—
Entry (qual.)
—
Exit (qual.)
—
Overall conviction 60%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how FINEORG fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain FINEORG for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
—
Consider buying FINEORG.NS around 4000 INR, as the shares appear to be oversold, and a sustained recovery in specialty chemicals demand could lead to a 10-15% upside potential.
simplywall.st·2d ago·dividend focus suggests stability
TradingView·4d ago·revenue split without trend data
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
36.49501 vs 34.35
6.24% surprise
| — |
| 13.98% |
| -4.60% |
| VINATIORGA | 135.80B | 30.58 | 14.90% | 23.15% | -6.90% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹4,783.00
Resistance (day/52w high)
₹4,864.50
Volume
6,077
Trend
down
RSI (14)
39
MACD
bearish
MA cross
golden
50-day MA
₹4,911.03
200-day MA
₹4,538.20
vs 200-DMA
5.6%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.